Innovating Advanced Antimicrobial Technologies for a Healthier World

Discover Polyamyna Nanotech Inc., a innovative biotechnology company headquartered in the vibrant city of St. John’s, Newfoundland and Labrador. At Polyamyna, we're not just a company – we're pioneers in the realm of advanced antimicrobial technologies, shaping the future of infection prevention and control.

Empowering Tomorrow's Health and Environment Through Innovation

Next-Gen Highly Durable Microbicidal Coating Technologies:

As part of our commitment to advancing infection prevention and control in healthcare settings, we specialize in next-gen highly durable microbicidal coating technologies. Our patent-pending coating technology features residual antimicrobial activity, providing unparalleled durability and long-lasting protection against drug-resistant pathogens on a variety of surfaces. By harnessing advanced material science, our coatings establish a formidable barrier against microbial colonization, ensuring a sustained inhospitable environment for microbial growth, aiding infection control.

Antimicrobial Fabrics

We engineer fabrics integrated with antimicrobial technologies, fostering hygienic environments in healthcare facilities, public spaces, and consumer products. Our antimicrobial fabrics inhibit the growth of clinically relevant drug-resistant pathogens, enhancing safety and comfort for users while maintaining superior durability and wash resistance.

Antifouling Technologies for Underwater Applications

Our antifouling coatings utilize advanced chemistry to prevent the accumulation of biofouling organisms on underwater surfaces, such as ship hulls and marine infrastructure. By inhibiting microbial attachment and growth, our technologies enhance operational efficiency, reduce maintenance costs, and minimize the environmental impact of marine transportation and offshore structures.

Anti-MIC Technologies for Defense and Aerospace

We develop antimicrobial coating technologies tailored for defense and aerospace applications, protecting critical surfaces from microbial contamination in extreme environments. Our Anti-MIC (Microbially Induced Corrosion) technologies safeguard equipment, aircraft, and infrastructure against the degradation caused by biofilm formation and microbial activity, ensuring operational reliability and longevity.

Point of Care Diagnostics for AMR Pathogens

Our portable point-of-care diagnostic device which is in R&D phase aimed to enable rapid and accurate identification of specific drug-resistant pathogens, empowering healthcare professionals to make informed treatment decisions at the bedside. By facilitating timely interventions, our diagnostics mitigate the spread of antimicrobial resistance and improve patient outcomes.


As part of our mission to pioneer innovations in drug discovery, we specialize in the development of novel antibiotic adjuvant therapeutics tailored towards human healthcare. Our solutions are dedicated to supporting the health and welfare of humans grappling with challenges of drug-resistant pathogens. We aim to ensure sustainable and effective management of infectious diseases that may negatively impact public health.